ACM
Armbruster Capital Management Portfolio holdings
AUM
$552M
This Quarter Return
+4.71%
1 Year Return
+14.32%
3 Year Return
+44.28%
5 Year Return
+79.81%
10 Year Return
–
AUM
$112M
AUM Growth
–
Cap. Flow
+$112M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
59.82%
Holding
305
New
305
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
$17.3M |
| 2 |
Invesco S&P 500 Pure Value ETF
RPV
|
$15.8M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$8.22M |
| 4 |
Invesco S&P SmallCap 600 Pure Value ETF
RZV
|
$5.94M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$4.61M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 3.73% |
| 2 | Consumer Staples | 3.56% |
| 3 | Healthcare | 3.51% |
| 4 | Energy | 2.7% |
| 5 | Industrials | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
26
DELISTED
Walgreens Boots Alliance
WBA
| $639K | 0.57% |
+7,500
| New | +$639K |
|
27
Colgate-Palmolive
CL
$67.7B
| $622K | 0.56% |
+9,340
| New | +$622K |
|
28
JPMorgan Chase
JPM
$824B
| $606K | 0.54% |
+9,184
| New | +$606K |
|
29
SPDR Dow Jones International Real Estate ETF
RWX
$301M
| $571K | 0.51% |
+14,600
| New | +$571K |
|
30
Digimarc
DMRC
$171M
| $556K | 0.5% |
+15,240
| New | +$556K |
|
31
AT&T
T
$208B
| $553K | 0.49% |
+21,259
| New | +$553K |
|
32
iShares Core S&P 500 ETF
IVV
$660B
| $543K | 0.48% |
+2,650
| New | +$543K |
|
33
Intel
INTC
$105B
| $517K | 0.46% |
+14,996
| New | +$517K |
|
34
Amgen
AMGN
$153B
| $492K | 0.44% |
+3,028
| New | +$492K |
|
35
Johnson & Johnson
JNJ
$429B
| $440K | 0.39% |
+4,288
| New | +$440K |
|
36
Microsoft
MSFT
$3.76T
| $439K | 0.39% |
+7,919
| New | +$439K |
|
37
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$9.63B
| $425K | 0.38% |
+4,575
| New | +$425K |
|
38
Constellation Brands
STZ
$25.8B
| $399K | 0.36% |
+2,800
| New | +$399K |
|
39
Schwab US Broad Market ETF
SCHB
$36.1B
| $392K | 0.35% |
+47,952
| New | +$392K |
|
40
PepsiCo
PEP
$203B
| $366K | 0.33% |
+3,658
| New | +$366K |
|
41
Bristol-Myers Squibb
BMY
$96.7B
| $361K | 0.32% |
+5,243
| New | +$361K |
|
42
3M
MMM
$81B
| $352K | 0.31% |
+2,799
| New | +$352K |
|
43
Procter & Gamble
PG
$370B
| $345K | 0.31% |
+4,344
| New | +$345K |
|
44
Merck
MRK
$210B
| $340K | 0.3% |
+6,755
| New | +$340K |
|
|
GRA
45
DELISTED
W.R. Grace & Co.
GRA
| $331K | 0.3% |
+3,323
| New | +$331K |
|
46
Vanguard Small-Cap ETF
VB
$65.9B
| $330K | 0.29% |
+2,987
| New | +$330K |
|
47
Eastman Chemical
EMN
$7.76B
| $320K | 0.29% |
+4,741
| New | +$320K |
|
48
Chevron
CVX
$318B
| $318K | 0.28% |
+3,531
| New | +$318K |
|
49
Coca-Cola
KO
$297B
| $318K | 0.28% |
+7,409
| New | +$318K |
|
50
CVS Health
CVS
$93B
| $290K | 0.26% |
+2,970
| New | +$290K |
|